ASPE: Aspen Neuroscience, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
4 open-market buys totaling $38.00M and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 60 | ASPE | Aspen Neuroscience, Inc. | Arch Venture Partners Xiv, L.P. / Arch Venture Partners Xiv, Llc / Arch Venture Fund Xiv, L.P. / Berns Paul L | 10% Owner | 2026-11-02 | $18.00M | new | 2 insiders |
| 53 | ASPE | Aspen Neuroscience, Inc. | Arch Venture Fund X, L.P. / Arch Venture Fund X Overage, L.P. / Arch Venture Partners X, L.P. / Arch Venture Partners X Overage, L.P. / Arch Venture Partners X, Llc / Crandell Keith / Burow Kristina / | 10% Owner | 2026-11-02 | $1000K | new | 2 insiders |
| 53 | ASPE | Aspen Neuroscience, Inc. | Arch Venture Fund X, L.P. / Arch Venture Fund X Overage, L.P. / Arch Venture Partners X, L.P. / Arch Venture Partners X Overage, L.P. / Arch Venture Partners X, Llc / Crandell Keith / Burow Kristina / | 10% Owner | 2026-11-02 | $1.00M | new | 2 insiders |
| 60 | ASPE | Aspen Neuroscience, Inc. | Arch Venture Fund X, L.P. / Arch Venture Fund X Overage, L.P. / Arch Venture Partners X, L.P. / Arch Venture Partners X Overage, L.P. / Arch Venture Partners X, Llc / Crandell Keith / Burow Kristina / | 10% Owner | 2026-11-02 | $18.00M | new | 2 insiders |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.